BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether BNC105P in combination with/following
everolimus is effective in the treatment of progressive metastatic clear cell renal cell
carcinoma following prior tyrosine kinase inhibitors.